China biotech’s CRISPR therapy suggests US drugmakers will face competitionnews2026-04-10T15:54:15+00:00April 10th, 2026|Endpoints News|
China-based CAR-T company Oricell raises $40M more as it looks to go publicnews2026-04-10T10:28:17+00:00April 10th, 2026|Endpoints News|
Gilead takes another big swing at expanding beyond HIVnews2026-04-08T15:10:43+00:00April 8th, 2026|Endpoints News|
David Sinclair startup Life Biosciences raises $80M for clinical test of anti-aging gene therapynews2026-04-08T12:00:17+00:00April 8th, 2026|Endpoints News|
Stipple Bio launches with $100M to find more precise targets on cancer proteinsnews2026-04-06T11:00:13+00:00April 6th, 2026|Endpoints News|
Aspect Biosystems gets $79M from Canadian government for diabetes cell therapynews2026-04-02T18:32:29+00:00April 2nd, 2026|Endpoints News|
Making custom CRISPR therapies could be harder than initially thoughtnews2026-04-01T19:40:47+00:00April 1st, 2026|Endpoints News|
FDA delays decision on Orca Bio cell therapy after filing more manufacturing datanews2026-04-01T12:00:29+00:00April 1st, 2026|Endpoints News|
Astellas doesn’t pick up AviadoBio’s gene therapy, but nonprofit funding will move it forwardnews2026-03-31T15:33:37+00:00March 31st, 2026|Endpoints News|
First clinical trial of tRNA therapy will start soonnews2026-03-31T11:00:50+00:00March 31st, 2026|Endpoints News|
